Biomarkers for antitumor activity of bevacizumab in gastric cancer models

BACKGROUND: Bevacizumab is a humanized monoclonal antibody to human vascular endothelial cell growth factor (VEGF) and has been used for many types of cancers such as colorectal cancer, non-small cell lung cancer, breast cancer, and glioblastoma. Bevacizumab might be effective against gastric cancer...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Yamashita-Kashima, Yoriko, Fujimoto-Ouchi, Kaori, Yorozu, Keigo, Kurasawa, Mitsue, Yanagisawa, Mieko, Yasuno, Hideyuki, Mori, Kazushige
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2012
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3292441/
https://ncbi.nlm.nih.gov/pubmed/22273502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-37
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi